Post by es/iode

📃Scientific paper: Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a systematic review and meta-analysis Ref.: Termedia Publishing House, 2024 What this work contributes: This systematic review evaluates the efficacy and safety of upadacitinib, a selective JAK1 inhibitor, in treating moderate-to-severe atopic dermatitis. The findings suggest that upadacitinib significantly reduces eczema severity and pruritus compared to placebo, though mild adverse events were more common. The study highlights the potential of upadacitinib as a treatment option, underscoring the need for further long-term research to solidify these outcomes. Read the curated record, source link, and metadata on ES/IODE: https://etcse.fr/haRL ------- Selected for researchers, analysts, and science watchers. Full source details are available on ES/IODE. #allergology #allergy #immunology #research #health